ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,572.85
0.10%
US Tech 100
19,893.60
0.00%
Dow Jones
39,344.79
-0.08%
Brent Oil
85.16
-0.30%
Bitcoin
57,360.53
1.15%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sangamo Therapeutics Inc (SGMO) Quote

Sangamo Therapeutics Inc

Sangamo Therapeutics Inc (SGMO)

NASDAQ
0.3184
0.00
(0.00%)
Closed July 09 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.3184
Bid
0.3112
Ask
0.325
Volume
-
0.00 Day's Range 0.00
0.2911 52 Week Range 1.67
Market Cap
66.071M
Previous Close
0.3184
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,922,807
Shares Outstanding
207,510,076
Dividend Yield
-
PE Ratio
-0.26
Earnings Per Share (EPS)
-1.24
Revenue
176.23M
Net Profit
-257.83M

About Sangamo Therapeutics Inc

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemoph... Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.sangamo.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Sangamo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SGMO. The last closing price for Sangamo Therapeutics was $0.32. Over the last year, Sangamo Therapeutics shares have traded in a share price range of $ 0.2911 to $ 1.67.

Sangamo Therapeutics currently has 207,510,076 shares outstanding. The market capitalization of Sangamo Therapeutics is $66.07 million. Sangamo Therapeutics has a price to earnings ratio (PE ratio) of -0.26.

SGMO Latest News

More News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

12 hours ago
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 13 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 06 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0131-3.951734539970.33150.35380.30422559800.32101667CS
4-0.2585-44.8084590050.57690.63250.30424196320.4189144CS
12-0.2385-42.82636020830.55690.70.30419228070.51014022CS
26-0.2016-38.76923076920.521.480.30421422120.69327172CS
52-1.0316-76.41481481481.351.670.291119661110.69305848CS
156-10.2316-96.981990521310.5511.490.291117066853.045639CS
260-10.9916-97.184792219311.3119.430.291117134076.08818314CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.175
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.2401
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.37
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.425
(0.00%)
0
AACGATA Creativity Global
$ 0.825
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.175
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.2401
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.37
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.425
(0.00%)
0
AACGATA Creativity Global
$ 0.825
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.175
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.2401
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.37
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.425
(0.00%)
0
AACGATA Creativity Global
$ 0.825
(0.00%)
0

SGMO Discussion

View Posts
georgie18 georgie18 7 days ago
It always sucks until it doesn't...🥳lets see where she lands...
👍️ 1
work-n-hard work-n-hard 7 days ago
The PPS sucks for now, but I'm taking chance that some sort of deal, that provides revenue will be reached this quarter. Kind of a All or Nothing type of thing.
I haven't added in weeks, but am bidding in a couple of spots below 30.
Good Luck if you are still holding.

https://www.nasdaq.com/market-activity/stocks/sgmo/analyst-research
šŸ‘ļø0
georgie18 georgie18 3 weeks ago
Thanks ...market closed yesterday ...lets see what today brings...🥳
šŸ‘ļø0
work-n-hard work-n-hard 3 weeks ago
SGMO: Looks like we're waiting on a Boom or Bust, no shares traded so far.
Estimated date of Ph. 3 Primary Completion was 06-17-24 and after that drop in PPS recently, which looked like a Short Cover Smackdown, I'm hoping for a move North at any time???
(Concerning the possible Smackdown. That could explain why we have no volume today. Shorts are out? IB's Borrow Rate is .8% today.)

https://clinicaltrials.gov/study/NCT04370054
šŸ‘ļø0
georgie18 georgie18 2 months ago
SGMO...6635...HOD...Trying for .70 Breakout again...🥳
👍️ 1
work-n-hard work-n-hard 2 months ago
https://www.barchart.com/stocks/quotes/SGMO/interactive-chart
šŸ‘ļø0
teifhals teifhals 2 months ago
Also has a lot of room to go up.
šŸ‘ļø0
work-n-hard work-n-hard 2 months ago
For anyone who can read ahead, yesterday's filing was not a shock. Look at the chart below and it will show the market knew it was coming.
But the news that came with it, about future developments actually sent the pps higher today than all week.
Some folks can't figure out why their trades fail. It's timing.

https://www.barchart.com/stocks/quotes/SGMO/interactive-chart
šŸ‘ļø0
DreamyMarauder100 DreamyMarauder100 2 months ago
Sangamo Therapeutics traded @ ( $0.2911 ) on ( November 13, 2023 ), this has a massive amount of room to go down ⏬ 🍂🍁 to that level again, especially with the earnings report that came out yesterday ( May 9, 2024 )
👍️ 1
DreamyMarauder100 DreamyMarauder100 2 months ago
Sangamo Therapeutics Flawless Balance ⚖️ Sheet And Extremely Undervalued... Fair Value ( $30.70 ) A Share
👍️ 1
DreamyMarauder100 DreamyMarauder100 2 months ago
Sangamo Therapeutics traded @ ( $0.2911 ) on ( November 13, 2023 ), this has a massive amount of room to go down ⏬ 🍂🍁 to that level again, especially with the earnings report coming out on Monday ( April 29, 2024 )
👍️ 1
seve333 seve333 3 months ago
It would seem so but as each do goes on the faith in sandy to get anything down keeps going down. Really hard to have any faith in that liar.
👍️ 1
seve333 seve333 3 months ago
They should not get a darn penny sandy drove the stock right back into the ground after the run to 1.40. He still cannot get a Farby deal done which is beyond absurd.
šŸ‘ļø0
jondoeuk jondoeuk 3 months ago
So they have chosen to not communicate with their customers as to the issue(s) and timing of a return? If they are closing down the website, then should have the courtesy of letting the paying customers know.
šŸ‘ļø0
jondoeuk jondoeuk 3 months ago
What?
šŸ‘ļø0
seve333 seve333 3 months ago
Whatever ryno
šŸ‘ļø0
Optionsrbest4u Optionsrbest4u 3 months ago
Investor Village site still down it seems. Has anyone heard anything re. a fix?
šŸ‘ļø0
work-n-hard work-n-hard 3 months ago
Thanks, but I don't think that far down the road with a stock who's PPS is at this level.
To me, these stocks are glorified Pinks.
JMO
šŸ‘ļø0
jondoeuk jondoeuk 3 months ago
They have cash until the end of Q3, but if additional funding isn't in place by then (at the latest) it's lights out. Shareholders should consider voting "against" a number of corporate incentives on the table. Officers should not be receiving bonuses this time around.
šŸ‘ļø0
work-n-hard work-n-hard 3 months ago
Looking like the climb back up, is still on track in the new month.
šŸ‘ļø0
jondoeuk jondoeuk 4 months ago
They have had countless secondaries over the years, but never an approved therapy. This company has been nothing more than a capital consuming beast created by Edward Lanphier, and he as well as others, mainly management taking shareholders to the cleaners, while they live in luxury! https://finance.yahoo.com/news/sangamo-therapeutics-announces-pricing-24-120500032.html
šŸ‘ļø0
work-n-hard work-n-hard 4 months ago
https://www.nasdaq.com/press-release/sangamo-therapeutics-announces-pricing-of-%2424.0-million-registered-direct-offering
šŸ‘ļø0
jondoeuk jondoeuk 4 months ago
From the 10-K: ''Based on our current operating plan, our cash, cash equivalents and marketable securities as of December 31, 2023 are expected to allow us to meet our liquidity requirements only into the third quarter of 2024. Although we have been actively seeking, and continue to actively seek, substantial additional capital, including through public or private equity or debt financing, royalty financing or other sources, such as strategic collaborations and other direct investments in our programs, we have been unsuccessful in securing any such additional capital to date. As a result, we have explored, and continue to explore, whether filing for bankruptcy protection is in the best interest of our Company and our stakeholders.''
šŸ‘ļø0
AliasUser1 AliasUser1 4 months ago
Bought some today. Risk/Reward is definitely worth it here.
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
Happy March another day another dollar close. Cheers.
šŸ‘ļø0
The Canes The Canes 4 months ago
It was critical! I hate reverse splits. That's where we were headed if we didn't hold a buck today. BRAVO!
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
Hey we close above a dollar over 10 days. Yes.
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
Today is our day. Iā€™m long SGMO and ATUS and ELTP and PLCE
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
Spreading the word. Buy SGMO. Hitting up Reddit we need them behind us. Cheers.
šŸ‘ļø0
The Canes The Canes 4 months ago
As I said there won't be any announcement regarding the earnings until after we close tomorrow. It's critical we stay above a dollar for 10 straight days. So tomorrow I expect the shorts to try and drive us below a dollar near the close. I have lots of ammo ready to buy the offer to fight the bastards off! You do the same amigo!
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
Big buyers. Are earning today????
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
You are correct. We are good.
šŸ‘ļø0
The Canes The Canes 4 months ago
We'll be good when we attain compliance after the close on Thursday. God willing the shorts don't upend that! Then and only then will the fool of a CEO announce the earnings call.
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
We are good
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
We have some good news coming. Cheers.
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
Good news coming my friends. Cheers.
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
I think early earnings next week maybe Monday. Looking good and feeling good.
šŸ‘ļø0
AliasUser1 AliasUser1 4 months ago
Could turn out to be good and go to 5+ somewhat quickly if things develop correctly. Cash burn will be pretty much cut in half this year too
šŸ‘ļø0
DNORWOOD DNORWOOD 4 months ago
I smell buyout or merger. Here we go. Volume is off the charts. All institutions and backdoor deals.
šŸ‘ļø0
DNORWOOD DNORWOOD 5 months ago
Here we
Go. Cheers.
šŸ‘ļø0
DNORWOOD DNORWOOD 5 months ago
Is Pfizer buying us out or just a friend?!?!????? Cheers.
šŸ‘ļø0
DNORWOOD DNORWOOD 5 months ago
We are going to the moon. Earnings coming and much much more. Cheers.
šŸ‘ļø0
Monksdream Monksdream 5 months ago
SGMO under $2
šŸ‘ļø0
Liam859 Liam859 5 months ago
$SGMO $1.45 busting ignore the noise
šŸ‘ļø0
trendzone trendzone 5 months ago
Earlier in the week some total creep manipulators were keeping it pinned at $0.73, if the were shorting they got their butt handed to them, if they were just some dumbass seller, they look like a total fool right now,with it at $1.35, corrupt Wall Street BS as usual, the biggest criminals walking on the earth today, steel from the public and give to their kind.
šŸ‘ļø0
Liam859 Liam859 5 months ago
$.82 the run begins
šŸ‘ļø0
Liam859 Liam859 6 months ago
$SGMO $0.55 buying it up here
šŸ‘ļø0
Penny Trades Penny Trades 7 months ago
Yeah maybe I should shirt the stock like you did, good idea, could have made big bucks lol
šŸ‘ļø0
Monksdream Monksdream 8 months ago
SGMO new 52 week low
šŸ‘ļø0
Monksdream Monksdream 9 months ago
I quite agree with your assessment of clinical stage bio companies as expensive experiments.
Out of curiosity I checked the reverse stock split history for Sangamo and came up with zero, which I found interesting.
Ever since Amgen went public in 1984 investors have placed high hopes on the possibility of hitting the Big One.

The biotech, biomed, medical device sector is actually the largest sector in terms of available public traded companies in which one
can invest. More go public every week.
The stock has certainly experienced some dramatic ups and downs since 2000

šŸ‘ļø0

Your Recent History

NASDAQ
SGMO
Sangamo Therapeutics
BIT
P1YJZ9
NLBNPIT1YJZ9 20991231 53...
BIT
S31911
Societe Generale Effekten
BIT
XXSC
Xtrackers MSCI EU Small ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved